Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation
- PMID: 16222702
- DOI: 10.1002/jcp.20502
Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation
Abstract
The HEXIM1 protein, in association with 7SK snRNA, binds and inhibits the kinase activity of P-TEFb (CDK9/cyclin T). P-TEFb activity is crucial for efficient transcription elongation of viral and cellular genes. HEXIM1 was originally isolated as a protein up-regulated by hexamethylene bisacetamide (HMBA), a prototypical inducer of differentiation. To determine the causative role of HEXIM1 during cell differentiation we analyzed the biochemical and functional consequences of HEXIM1 protein levels in several in vitro differentiation systems. We found that HEXIM1 mRNA and protein levels are up-regulated during differentiation of murine erythroleukemia cells upon treatment with HMBA or DMSO. Stimulation of HEXIM1 is not restricted to hematopoietic cells, as induction of phenotypic differentiation of neuroblastoma cells by retinoic acid results in up-regulation of HEXIM1. Moreover, ectopic expression of HEXIM1 causes growth inhibition and promotes neuronal differentiation. These findings highlight a crucial role of HEXIM1 protein during cell differentiation.
Copyright 2005 Wiley-Liss, Inc.
Similar articles
-
Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17349-54. doi: 10.1073/pnas.0603079103. Epub 2006 Nov 6. Proc Natl Acad Sci U S A. 2006. PMID: 17088550 Free PMC article.
-
The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.Mol Cell Biol. 2007 Oct;27(20):6996-7006. doi: 10.1128/MCB.00975-07. Epub 2007 Aug 20. Mol Cell Biol. 2007. PMID: 17709395 Free PMC article.
-
Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.Mol Cell. 2003 Oct;12(4):971-82. doi: 10.1016/s1097-2765(03)00388-5. Mol Cell. 2003. PMID: 14580347
-
RNA-driven cyclin-dependent kinase regulation: when CDK9/cyclin T subunits of P-TEFb meet their ribonucleoprotein partners.Biotechnol J. 2008 Aug;3(8):1022-32. doi: 10.1002/biot.200800104. Biotechnol J. 2008. PMID: 18655042 Review.
-
Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.Biomed Res Int. 2014;2014:232870. doi: 10.1155/2014/232870. Epub 2014 Jan 29. Biomed Res Int. 2014. PMID: 24592384 Free PMC article. Review.
Cited by
-
CDK9: A Comprehensive Review of Its Biology, and Its Role as a Potential Target for Anti-Cancer Agents.Front Oncol. 2021 May 10;11:678559. doi: 10.3389/fonc.2021.678559. eCollection 2021. Front Oncol. 2021. PMID: 34041038 Free PMC article. Review.
-
HMBA ameliorates obesity by MYH9- and ACTG1-dependent regulation of hypothalamic neuropeptides.EMBO Mol Med. 2023 Dec 7;15(12):e18024. doi: 10.15252/emmm.202318024. Epub 2023 Nov 20. EMBO Mol Med. 2023. PMID: 37984341 Free PMC article.
-
Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.Blood. 2008 Dec 15;112(13):4884-94. doi: 10.1182/blood-2008-03-145722. Epub 2008 Sep 9. Blood. 2008. PMID: 18780834 Free PMC article.
-
CDK9 inhibitors in acute myeloid leukemia.J Exp Clin Cancer Res. 2018 Feb 23;37(1):36. doi: 10.1186/s13046-018-0704-8. J Exp Clin Cancer Res. 2018. PMID: 29471852 Free PMC article. Review.
-
Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.Cancer Lett. 2016 Aug 28;379(1):60-9. doi: 10.1016/j.canlet.2016.05.029. Epub 2016 May 26. Cancer Lett. 2016. PMID: 27238569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
